
Afshin Farzaneh-Far, MD PhD
@afshinfarzan
Cardiologist & Researcher via @EdinburghUni @Cambridge_Uni @RBandH @nyphospital @BrighamWomens @DukeHeartCenter #DrugDevelopment #whyCMR #CardiacImaging
ID: 3493359315
30-08-2015 17:54:27
1,1K Tweet
2,2K Followers
1,1K Following

Study categorisation from Stuart Pocock at #PratoAnaes2022 ➡️ WOW! and PHEW! interpreted the same but very different ➡️ PHEW! and DAMN! interpreted differently but virtually the same We need to get wiser, a p-value is no substitute for brain.


(1/10) Today the long-awaited full results from the Phase 3 ATTRibute-CM trial were presented European Society of Cardiology #ESCCongress. We already knew the topline results from last month: Acoramidis made a (big) difference in outcomes! What more did we learn?🤔Let's dig deeper...











Do GLP-1 agonists make you eat more healthy foods? Slide from Morgan Stanley shown by Dr John Deanfield UCL Royal Brompton and Harefield grand rounds #MedTwitter #CardioTwitter #GLP1 #obesity




In long term follow-up of the SPINS registry "peri-infarct ischemia" assessed by stress perfusion CMR may have independent prognostic value: jacc.org/doi/10.1016/j.… With accompanying editorial: jacc.org/doi/10.1016/j.… Raymond Kwong Sven Plein



🔥🔥 Hot off the press 🔥🔥 #Strain in primary #MR with #WhyCMR ➡️ GLS may serve as a marker of cardiac dysfunction in primary MR patients with preserved #LVEF allowing identification of patients likely to decompensate during observation ➡️ academic.oup.com/ehjcimaging/ad… European Society of Cardiology Journals


New blog article challenging medical researchers who are drawn to clustering patients to create so-called "phenotypes" to think again: fharrell.com/post/cluster Maarten van Smeden “Darren Dahley” #Statistics #PrecisionMedicine @vandy_biostat